BioHarvest Sciences Inc.

Good morning and welcome to the BioHarvest Sciences second quarter 2026 financial results conference call. As a reminder, all participants are in listen-only mode. A question and answer session will follow the formal presentation. If you would like to ask a question, please press star 1 on your phone. To withdraw your question, please press star 1 again. As a reminder, this conference is being recorded. I will now hand the call over to Dori Kurowski of LifeSci Advisors. Please go ahead.

Greetings and welcome to the BioHarvest Sciences Second Quarter 2026 Financial Results Conference Call. With us on the call this morning is Dr. Zaki Rakib, Chairman and Chief Executive Officer. Before we begin, I'd like to remind you that management will be making projections and forward-looking statements on the call today regarding future events. Any statements that are not historical facts are forward-looking statements. These statements are made pursuant to and within the meaning of the safe harbor provision of the Private Securities Litigation Reform Act of 1995. We encourage you to review BioHarvest Sciences SEC filings, including the company's most recent form 6K, which identify risks and uncertainties that may cause future actual results or events to differ materially. These filings can be found on the company website as well as the SEC's website at www.sec.gov. Please note that the forward-looking statements made during today's call speak only to the date they are made, and BioHarvest Sciences undertakes no obligation to update them. And with that, I would like to turn the call over to Dr. Zaki Rakib, Chief Executive Officer of BioHarvest. Please go ahead.

Hello, Dr. Zaki, just a reminder to unmute, please.